Impact of Roux-En-Y Pouch Reconstruction Compared With Conventional Roux-En-Y Reconstruction on Quality of Life in Patients Undergoing Total Gastrectomy
NCT ID: NCT01697943
Last Updated: 2012-10-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
140 participants
INTERVENTIONAL
2012-05-31
2017-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients with total gastrectomy suffer from poor food intake, anemia, and poor digestion because of loss of gastric reservoir or a lack of normal hormonal secretion for digestion. It often is associated with a limitation of postoperative quality of life (QOL). To improve postoperative nutritional status and QOL, surgeons have tried to establish ideal reconstruction after total gastrectomy and the optimum procedure for reconstruction has been discussed.
This study will compare the postoperative quality of life (QOL) of gastric pouch reconstruction with the usual reconstruction to see if the pouch makes patients feel better.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Roux-En-Y Pouch Reconstruction or Roux-En-Y Reconstruction
Roux-En-Y Pouch Reconstruction or Conventional Roux-En-Y Reconstruction
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Roux-En-Y Pouch Reconstruction or Conventional Roux-En-Y Reconstruction
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients 20-75 years old
* Normal organ function, able to tolerate surgery, no clear contraindication for surgery
* No evidence of metastases of adjacent organs
* be able to provide follow-up over 2 years
* No specific treatment for gastric cancer before surgery
* In line with the Declaration of Helsinki and the requirements of the hospital ethics committee.
* The subjects were able to understand and comply with the trial protocol, and signed informed consent.
Exclusion Criteria
* Cirrhosis and portal hypertension
* Associated with blood diseases
* Serious heart/ lung and kidney dysfunction or with metabolic diseases such as diabetes, hyperthyroidism.
* Suffering from a serious neurological diseases or psychological diseases affecting the life
20 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fudan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yanong Wang
Director of Department of Abdominal Surgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ya Nong Wang, MD,PhD
Role: primary
Hua Huang, MD,PhD
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2012-44-563
Identifier Type: -
Identifier Source: org_study_id